Breast cancer survivor offers wisdom at Faulkner satellite center
Call 877-422-3324 today to make an appointment
Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.
Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.
Toll-Free Number866-408-DFCI (3324)
Discover the ways to give and how to get involved to support Dana-Farber.
Poet Richard Fox gains insight – and material – through cancer treatment
A family faces cancer in an unfamiliar city – with help
Choosing mastectomy or not: Studying young women's surgical choices
Jeff's targeted therapy has kept his advanced lung cancer at bay.
Make Your First AppointmentGet a Second Opinion
Call us: 877-442-3324
The Susan F. Smith Center for Women's Cancers at Dana-Farber unites many of the world's leading experts in breast and gynecologic cancers with one common goal: to give all women the latest, most advanced care, including innovative therapies that are often available only through clinical trials.
The Susan F. Smith Center for Women's Cancers creates powerful possibilities by bridging compassionate care with world-class basic and clinical research. A place of hope and action, we offer a full spectrum of services that nourish body, mind, and spirit. From the moment a patient arrives for her first appointment to the day her treatment ends, we surround her with a circle of support.
Donna GregoryCancer patient
Our physicians are deeply committed to providing expert, compassionate care and to conducting active research to benefit current patients and future generations of women.
Dr. Ursula A. Matulonis is interim director of the Susan F. Smith Center for Women's Cancers and medical director of the Gynecologic Oncology Program. She is an Associate Professor of Medicine at Harvard Medical School. Her research focuses on targeted therapies for gynecologic malignancies, with a specific interest in the genetic changes in ovarian cancer and how that can lead to rationale targeted drug selection. Dr. Matulonis is the Principal Investigator of several clinical trials and translational studies for ovarian cancer.Additional Biographical InformationFull Treatment Team
Dr. Eric Winer received his MD from Yale University in 1983, and later completed training in internal medicine and served as chief resident at Yale-New Haven Hospital. He subsequently was a fellow in hematology-oncology at Duke University Medical Center. From 1989 to 1997, Dr. Winer served on the Duke faculty, where he became co-director of the multidisciplinary breast program. In 1997, he joined Dana-Farber/Brigham and Women’s Cancer Center, where he serves as director of the Susan F. Smith Center for Women's Cancers Breast Oncology Program. Dr. Winer is also the chief of the Division of Women's Cancers at Dana-Farber and the Thompson Senior Investigator in Breast Cancer Research. He is a Professor of Medicine at Harvard Medical School.Additional Biographical InformationFull Treatment Team
Dr. Judy Garber is the director of the Center for Cancer Genetics and Prevention. She received her MD and MPH in 1981 from Yale University School of Medicine. She served her internal medicine residency at Brigham and Women's Hospital (BWH), followed by fellowships in hematology at BWH, medical oncology at Dana-Farber, and biostatistics at the National Cancer Institute. She joined Dana-Farber as a fellow in 1985, and now works as a medical oncologist and clinical cancer geneticist. Dr. Garber is a Professor of Medicine at Harvard Medical School.Additional Biographical InformationFull Treatment Team
Support Research and Treatment at the Susan F. Smith Center